Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Holl, Daniel ^a   Kuckenberg, Peter ^a   Woynecki, Tatiana ^a   Egert, Angela ^a   Becker, Astrid ^a   Huss, Sebastian ^a   Stabenow, Dirk ^a   Zimmer, Andreas ^a   Knolle, Percy ^a   Tolba, René ^b   Fischer, Hans Peter ^a   Schorle, Hubert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAT DROPLET; LIPIN 2 PROTEIN, MOUSE; LPIN1 PROTEIN, MOUSE; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDATE PHOSPHATASE; TCFAP2C PROTEIN, MOUSE; TRANSCRIPTION FACTOR AP 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYPT CELL; EMBRYO; FATTY LIVER; GASTROINTESTINAL DYSPLASIA; GENE; GENE INDUCTION; GENE OVEREXPRESSION; INTESTINE EPITHELIUM CELL; LIVER CELL CULTURE; LIVER FAILURE; LIVER METABOLISM; MOUSE; NONHUMAN; STEM CELL EXPANSION; TCFAP2C GENE; TRANSGENE; ANIMAL; CELL CULTURE; DNA MICROARRAY; ENTEROPATHY; GENETICS; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

MAMMALIA; MUS; MUS MUSCULUS;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; INTESTINAL DISEASES; LIPID METABOLISM; LIVER FAILURE; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHATIDATE PHOSPHATASE; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTOR AP-2;

EID: 79960240793     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022034     Document Type: Article

References (49)

1. Williams T, Admon A, Lüscher B, Tjian R, (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 2: 1557-1569.
2. Moser M, Imhof A, Pscherer A, Bauer R, Amselgruber W, et al. (1995) Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development (Cambridge, England) 121: 2779-2788.
3. Oulad-Abdelghani M, Bouillet P, Chazaud C, Dollé P, Chambon P, (1996) AP-2.2: a novel AP-2-related transcription factor induced by retinoic acid during differentiation of P19 embryonal carcinoma cells. Exp Cell Res 225: 338-347.
4. Zhao F, Satoda M, Licht JD, Hayashizaki Y, Gelb BD, (2001) Cloning and characterization of a novel mouse AP-2 transcription factor, AP-2delta, with unique DNA binding and transactivation properties. J Biol Chem 276: 40755-40760.
5. Feng W, Williams T, (2003) Cloning and characterization of the mouse AP-2 epsilon gene: a novel family member expressed in the developing olfactory bulb. Mol Cell Neurosci 24: 460-475.
6. Auman HJ, Nottoli T, Lakiza O, Winger Q, Donaldson S, et al. (2002) Transcription factor AP-2gamma is essential in the extra-embryonic lineages for early postimplantation development. Development 129: 2733-2747.
7. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T, (1998) AP-2-null cells disrupt morphogenesis of the eye, face, and limbs in chimeric mice. Proc Natl Acad Sci U S A 95: 13714-13719.
8. Schorle H, Meier P, Buchert M, Jaenisch R, Mitchell PJ, (1996) Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381: 235-238.
9. Werling U, Schorle H, (2002) Transcription factor gene AP-2 gamma essential for early murine development. Molecular and Cellular Biology 22: 3149-3156.
10. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, et al. (1996) Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381: 238-241.
11. Eckert D, Buhl S, Weber S, Jäger R, Schorle H, (2005) The AP-2 family of transcription factors. Genome Biol 6: 246.
12. Chazaud C, Oulad-Abdelghani M, Bouillet P, Décimo D, Chambon P, et al. (1996) AP-2.2, a novel gene related to AP-2, is expressed in the forebrain, limbs and face during mouse embryogenesis. Mech Dev 54: 83-94.
13. Jäger R, Schäfer S, Hau-Liersch M, Schorle H, (2010) Loss of transcription factor AP-2gamma/TFAP2C impairs branching morphogenesis of the murine mammary gland. Dev Dyn 239: 1027-1033.
14. Kuckenberg P, Buhl S, Woynecki T, Van Furden B, Tolkunova E, et al. (2010) The Transcription Factor TCFAP2C/AP-2 Cooperates with CDX2 To Maintain Trophectoderm Formation. Molecular and cellular biology 30: 3310-3320.
15. Weber S, Eckert D, Nettersheim D, Gillis AJM, Schäfer S, et al. (2010) Critical function of AP-2 gamma/TCFAP2C in mouse embryonic germ cell maintenance. Biology of Reproduction 82: 214-223.
16. Pinto L, Drechsel D, Schmid MT, Ninkovic J, Irmler M, et al. (2009) AP2gamma regulates basal progenitor fate in a region- and layer-specific manner in the developing cortex. Nat Neurosci 12: 1229-1237.
17. Friedrichs N, Jager R, Paggen E, Rudlowski C, Merkelbach-Bruse S, et al. (2005) Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer. Mod Pathol 18: 431-438.
18. Gee JM, Robertson JF, Ellis IO, Nicholson RI, Hurst HC, (1999) Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer. J Pathol 189: 514-520.
19. Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietilainen T, et al. (2002) Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. Clin Cancer Res 8: 3487-3495.
20. Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, et al. (1998) Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res 58: 5466-5472.
21. Oyama N, Takahashi H, Tojo M, Iwatsuki K, Iizuka H, et al. (2002) Different properties of three isoforms (alpha, beta, and gamma) of transcription factor AP-2 in the expression of human keratinocyte genes. Arch Dermatol Res 294: 273-280.
22. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, et al. (2004) Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10: 8521-8530.
23. Pauls K, Jager R, Weber S, Wardelmann E, Koch A, et al. (2005) Transcription factor AP-2gamma, a novel marker of gonocytes and seminomatous germ cell tumors. Int J Cancer 115: 470-477.
24. Zhao C, Yasui K, Lee CJ, Kurioka H, Hosokawa Y, et al. (2003) Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis. Cancer 98: 18-23.
25. Ailan H, Xiangwen X, Daolong R, Lu G, Xiaofeng D, et al. (2009) Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells. BMC Cancer 9: 279.
26. Pellikainen JM, Kosma V-M, (2007) Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. Int J Cancer 120: 2061-2067.
27. Thewes V, Orso F, Jäger R, Eckert D, Schäfer S, et al. (2010) Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells. BMC Cancer 10: 192.
28. Williams CMJ, Scibetta AG, Friedrich JK, Canosa M, Berlato C, et al. (2009) AP-2gamma promotes proliferation in breast tumour cells by direct repression of the CDKN1A gene. EMBO J 28: 3591-3601.
29. Woodfield GW, Chen Y, Bair TB, Domann FE, Weigel RJ, (2010) Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells. Genes Chromosomes Cancer 49: 948-962.
30. Bosher JM, Williams T, Hurst HC, (1995) The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci U S A 92: 744-747.
31. Li H, Goswami PC, Domann FE, (2006) AP-2gamma induces p21 expression, arrests cell cycle, and inhibits the tumor growth of human carcinoma cells. Neoplasia 8: 568-577.
32. Jäger R, Werling U, Rimpf S, Jacob A, Schorle H, (2003) Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model. Mol Cancer Res 1: 921-929.
33. Lind AB, Wadelius M, Darj E, Finnstrom N, Lundgren S, et al. (2003) Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol Toxicol 92: 295-299.
34. Wang Q, Williamson M, Bott S, Brookman-Amissah N, Freeman A, et al. (2007) Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer. Oncogene 26: 6560-6565.
35. Gee J, Eloranta J, Ibbitt J, Robertson J, Ellis I, et al. (2009) Overexpression ofTFAP2Cin invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival. J Pathol 217: 32-41.
36. Kidder BL, Palmer S, (2010) Examination of transcriptional networks reveals an important role for TCFAP2C, SMARCA4, and EOMES in trophoblast stem cell maintenance. Genome Research 20: 458-472.
37. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, et al. (2004) SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 166: 37-47.
38. Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, et al. (2009) Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver Physiol 296: G1108-1118.
39. Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, et al. (2011) Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43: 34-41.
40. Hochedlinger K, Yamada Y, Beard C, Jaenisch R, (2005) Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477.
41. Beard C, Hochedlinger K, Plath K, Wutz A, Jaenisch R, (2006) Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (New York, NY: 2000) 44.
42. Gomez-Lechon MJ, Jover R, Donato MT, (2009) Cytochrome p450 and steatosis. Curr Drug Metab 10: 692-699.
43. Finck BN, Gropler MC, Chen Z, Leone TC, Croce MA, et al. (2006) Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab 4: 199-210.
44. Gropler MC, Harris TE, Hall AM, Wolins NE, Gross RW, et al. (2009) Lipin 2 is a liver-enriched phosphatidate phosphohydrolase enzyme that is dynamically regulated by fasting and obesity in mice. J Biol Chem 284: 6763-6772.
45. Yu S, Rao S, Reddy JK, (2003) Peroxisome proliferator-activated receptors, fatty acid oxidation, steatohepatitis and hepatocarcinogenesis. Curr Mol Med 3: 561-572.
46. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, et al. (2007) The H19 non-coding RNA is essential for human tumor growth. PLoS ONE 2: e845.
47. Gabory A, Jammes H, Dandolo L, (2010) The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays 32: 473-480.
48. Hao J, Serohijos AW, Newton G, Tassone G, Wang Z, et al. (2008) Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancers. PLoS Comput Biol 4: e1000138.
49. Dorrell C, Erker L, Schug J, Kopp JL, Canaday PS, et al. Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 25: 1193-1203.